BIRC5 and neoplasm: Both, a knock down by shRNAs as well as the transcriptional repression of survivin by small molecule antagonist YM155 demonstrated a pronounced effect on cell viability and tumor formation in a xenograft mouse model (Dizdar et al. 2017).